TrialCardiovascular diabetology2025

Effects of dapagliflozin on the progression of left ventricular dysfunction in type 2 diabetes mellitus: a randomized controlled trial.

Thomas H Marwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.